NCT03432117

Brief Summary

This trial is multicenter prospective study to evaluate clinical efficacy of respiratory rehabilitation personalized mobile services for respiratory disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
179

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2017

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2018

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

January 22, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 14, 2018

Completed
Last Updated

February 28, 2018

Status Verified

February 1, 2018

Enrollment Period

8 months

First QC Date

January 22, 2018

Last Update Submit

February 27, 2018

Conditions

Keywords

respiratory rehabilitationpersonalized mobile services

Outcome Measures

Primary Outcomes (3)

  • change from baseline in Modified Medical Research Council dyspnea score

    The MMRC dyspnea scale is a five-option grading system. The scale measures a person's limitation base on a scale of 0-4 and uses the final value to determine how much disability is caused by shortness of breath.

    12 weeks

  • change from baseline in COPD Assessment Test(CAT) score

    The CAT is a validated, short and simple subject completed questionnaire which has been developed for use in routine clinical practice to measure the health status of subjects with COPD. Subjects are scored on eight items (cough, phlegm, chest tightness, breathlessness, activity limitation, confidence, sleep and energy) on a scale of 0-5 depending on their impact. The sum of scores for each item gives the subject's impact score ranging from 0 (no impact) to 40 (worst possible impact).

    12 weeks

  • change from baseline in real distance walked for 6 minutes

    12 weeks

Secondary Outcomes (6)

  • change from baseline in Physical activity

    12 weeks

  • subject satisfaction with health status

    12 weeks

  • subject satisfaction with service

    12 weeks

  • change in Healthcare resource utilisation(the number of hospitalization) in COPD(chronic obstructive pulmonary disease) Patients

    12 weeks

  • change in Healthcare resource utilisation(hospitalization period) in COPD(chronic obstructive pulmonary disease) Patients

    12 weeks

  • +1 more secondary outcomes

Study Arms (3)

Fixed respiratory rehabilitation program(A)

EXPERIMENTAL

respiratory rehabilitation program for 12 weeks

Other: Fixed respiratory rehabilitation

Mixed respiratory rehabilitation program(B)

EXPERIMENTAL

Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks

Other: Fixed respiratory rehabilitationOther: Responsive respiratory rehabilitation

Control(C)

NO INTERVENTION

Ordinary rehabilitation service of the site for 12 weeks

Interventions

There are 6 step-exercise presented in the application and initial target of exercise will be set according to subject condition. After subject completes targeted exercise, next step will be started.

Fixed respiratory rehabilitation program(A)Mixed respiratory rehabilitation program(B)

The application provide responsive exercise program by changing type and numbers of exercise according to subject condition and exercise ability (This will be assessed with monitored O2 saturation, symptom of dyspnea and pulse rate during exercise)

Mixed respiratory rehabilitation program(B)

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Lung cancer or COPD
  • Patients with FEV1\<80% or FVC\<80% in Pulmonary function test
  • In case of COPD, post-bronchodilator FEV1 or FVC will be used.
  • Exceptionally Lung Cancer patients with operation, FEV1\>80% or FVC\>80% will be permitted
  • The distance walked for 6 minutes in 6-minute walk test ≥ 150 m
  • Patients with android phone
  • Patients who voluntarily agree to study participation and provide written informed consent form

You may not qualify if:

  • Patients with diseases which could be cause of death or significant disability for 1 year after study enrollment.
  • Patients with diseases that are difficult to walk or improve walking at screening
  • Patients with significant diseases which are difficult to include in this study in accordance with the investigator's judgment
  • Patients who are illiterate or have communication limitations
  • Patients who have a difficulty to complete a questionnaire or are uncooperative due to deterioration of recognition function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Wonju Severance Christian Hospital

Wŏnju, Gangwon-do, 26426, South Korea

Location

Hanyang University Guri Hospital

Guri-si, Gyeonggi-do, 11923, South Korea

Location

KyungHee University Medical Center

Seoul, 02447, South Korea

Location

Asan Medical Center

Seoul, 05505, South Korea

Location

Smg-Snu Boramae Medical Center

Seoul, 07061, South Korea

Location

Related Publications (2)

  • Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2.

  • Kwon H, Lee S, Jung EJ, Kim S, Lee JK, Kim DK, Kim TH, Lee SH, Lee MK, Song S, Shin K. An mHealth Management Platform for Patients with Chronic Obstructive Pulmonary Disease (efil breath): Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Aug 24;6(8):e10502. doi: 10.2196/10502.

MeSH Terms

Conditions

Respiration DisordersLung NeoplasmsPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesLung Diseases, ObstructiveChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The subjets were randomized(1:1:1) to 3 group(A: Fixed respiratory rehabilitation program group, B: Mixed respiratory rehabilitation program group( Fixed respiratory rehabilitation for 6 weeks, and then responsive respiratory rehabilitation for 6 weeks) and C: Control group(Ordinary rehabilitation service of the site).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

January 22, 2018

First Posted

February 14, 2018

Study Start

May 15, 2017

Primary Completion

December 28, 2017

Study Completion

January 6, 2018

Last Updated

February 28, 2018

Record last verified: 2018-02

Locations